Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study

To assess intensification approaches with basal insulin (BI) following glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment in type 2 diabetes (T2D). Real-world data were collected in electronic medical records by 32 Italian diabetes clinics between 2011 and 2021. Primary endpoint was the p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nutrition, metabolism, and cardiovascular diseases metabolism, and cardiovascular diseases, 2023-11, Vol.33 (11), p.2294-2305
Hauptverfasser:	Candido, Riccardo, Nicolucci, Antonio, Larosa, Monica, Rossi, Maria Chiara, Napoli, Raffaele, Gabellieri, Enrico, Tortato, Elena, Rabini, Rosa Anna, Crazzolara, Dalia, Lucibelli, Luigi, Aragiusto, Concetta, Panzolato, Gianluigi, Di Mauro, Maurizio, Del Buono, Andrea, Placentino, Giuseppe, Di Cianni, Graziano, Brandoni, Gabriele, Fazion, Stefano, Gregori, Giovanna, Di Benedetto, Antonino, De Riva, Carlo, Terracciano, Annamaria, Zenari, Luciano, Cavalot, Franco, Porcellati, Francesca, Anichini, Roberto, Citro, Giuseppe, D'Angelo, Paola, Arca, Marcello, Morviducci, Lelio, Montani, Valeria, Fiorentini, Paolo
Format:	Artikel
Sprache:	eng
Schlagworte:	Basal insulin Effectiveness Fixed-ratio combination GLP-1 receptor agonists Insulin naïve Safety Type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!